Caption Management, LLC Repligen Corp Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Caption Management, LLC holds 50,000 shares of RGEN stock, worth $7.23 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$7.23 Million
Previous $6.36 Million
2.25%
% of portfolio
0.08%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
510Shares Held
59MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$955 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$734 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$277 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$235 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.02B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....